Innophos (IPHS) Announces Earnings Results

Innophos (NASDAQ:IPHS) posted its quarterly earnings results on Wednesday. The specialty chemicals company reported $0.52 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.56 by ($0.04), Bloomberg Earnings reports. Innophos had a return on equity of 13.90% and a net margin of 6.19%. The business had revenue of $193.10 million for the quarter, compared to analyst estimates of $194.25 million. During the same quarter in the prior year, the firm earned $0.52 EPS. The firm’s quarterly revenue was up 15.1% on a year-over-year basis.

Shares of Innophos (NASDAQ IPHS) traded up $0.99 during trading hours on Thursday, hitting $43.66. 219,700 shares of the stock traded hands, compared to its average volume of 119,939. Innophos has a 52 week low of $40.45 and a 52 week high of $55.65. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.86 and a quick ratio of 1.49. The firm has a market cap of $833.30, a P/E ratio of 20.12 and a beta of 0.76.

IPHS has been the topic of a number of recent research reports. BidaskClub upgraded shares of Innophos from a “hold” rating to a “buy” rating in a research note on Friday, December 22nd. Zacks Investment Research upgraded shares of Innophos from a “hold” rating to a “buy” rating and set a $50.00 price target on the stock in a research note on Friday, December 15th. Finally, KeyCorp reiterated a “hold” rating on shares of Innophos in a research note on Wednesday, November 1st.

Several large investors have recently modified their holdings of the company. The Manufacturers Life Insurance Company boosted its stake in shares of Innophos by 0.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 14,962 shares of the specialty chemicals company’s stock valued at $656,000 after purchasing an additional 130 shares in the last quarter. Public Employees Retirement System of Ohio boosted its stake in shares of Innophos by 5.9% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock valued at $124,000 after purchasing an additional 157 shares in the last quarter. Voya Investment Management LLC boosted its stake in shares of Innophos by 8.2% in the 2nd quarter. Voya Investment Management LLC now owns 10,214 shares of the specialty chemicals company’s stock valued at $448,000 after purchasing an additional 776 shares in the last quarter. Stevens Capital Management LP boosted its stake in shares of Innophos by 18.0% in the 3rd quarter. Stevens Capital Management LP now owns 7,006 shares of the specialty chemicals company’s stock valued at $345,000 after purchasing an additional 1,070 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of Innophos by 13.6% in the 3rd quarter. Victory Capital Management Inc. now owns 12,166 shares of the specialty chemicals company’s stock valued at $598,000 after purchasing an additional 1,455 shares in the last quarter. Institutional investors own 96.54% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/02/21/innophos-iphs-issues-quarterly-earnings-results-misses-estimates-by-0-03-eps.html.

About Innophos

Innophos Holdings, Inc is an international producer of specialty ingredient solutions that deliver for the food, health, nutrition and industrial markets. The Company’s segments include Food, Health and Nutrition, Industrial Specialties and Other. It offers a range of product categories, such as asphalt, catalyst, fertilizer salts, liquid phosphate, phosphate salt, phosphoric acid, polyphosphoric acid, sodium bicarbonate, and food blends.

Earnings History for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply